EFMC-ACSMEDI MedChem Frontiers 2019

Joint Symposium on Medicinal Chemistry Frontiers

 Krakow, Poland    June 10-13, 2019

The chemistry-driven company active in design and synthesis of novel building blocks and compound libraries. Enamine offers the world’s largest collection of building blocks (906,000) and screening compounds (2,600,000) including 110,550 fragments. Comprehensive services in lead discovery and optimization are available including integrated biomolecular and ADME/Tox screening, all on-site.


A competitive chemical supplier of reagent and building blocks for research and development to the pharmaceutical companies, universities and those performing contract research.

Home of the new search facility “Doug Discovery”. Come and ask for a demo alternatively check it out yourself at www.dougdiscovery.com.

Iktos is a French start-up company which develops a disruptive artificial intelligence technology for ligand and structure-based de novo drug design. Our innovative algorithm is based on state-of-the-art deep learning models, called generative models, and enables to design new, druggable and synthesizable molecules under the constraint of a given blueprint, with unprecedented speed and performance.


Manchester Organics specialise in fluorination and high-pressure chemistry, research and manufacturing. Our expertise in fluorination and general organic synthesis at all scales allows us to provide an extensive range of fine chemicals through our catalogue, as well as servicing a chemically diverse range of custom synthesis, development and scale-up projects.


MercachemSyncom is the leading mid-sized European drug-discovery CRO for solving your chemistry challenges, from small to medium-sized molecule hits, to the first GMP batches of identified clinical candidates. We blend vast scientific knowledge with inventiveness to make great leaps on your behalf. We go further to unlock new potential.


Optibrium provides software for drug design, optimisation and data analysis. It’s lead product, StarDrop, is a comprehensive suite of integrated software with a highly visual and user-friendly interface. StarDrop enables a seamless flow from the latest data through to predictive modelling and decision-making regarding the next round of synthesis and research, improving the speed, efficiency, and productivity of discovery.


PerkinElmer is a global leader committed to innovating for a healthier world. Our dedicated team is passionate about providing customers with an unmatched experience as they help solve critical issues especially impacting the diagnostics and discovery and analytical solutions markets. Our innovative detection, imaging, informatics, and service capabilities, combined with deep market knowledge and expertise, help customers gain earlier and more accurate insights to improve lives and the world around us.


Selvita S.A. is a clinical stage drug discovery company engaged in the research and development of novel cancer therapies, as well as provision of integrated drug discovery services. Selvita is headquartered in Krakow with offices in the U.S. and U.K. The company is listed on the Warsaw Stock Exchange (WSE:SLV).